×
About 60 results

ALLMedicine™ Anagen Effluvium Center

Research & Reviews  20 results

Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection...
https://doi.org/10.1111/1346-8138.16475
The Journal of Dermatology; Ohyama M, Matsudo K et. al.

May 29th, 2022 - Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a pandemic by the World Health Organization, and COVID-19 continues to have a major impact on society. Numerous studies have re...

The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111640
Dermatologic Therapy; Aryanian Z, Balighi K et. al.

Mar 11th, 2022 - The prevalence of hair loss has increased during COVID-19. In this study, we review the current literature on incidence and characteristics of various types of COVID-19-related and COVID-19-vaccine- related hair loss including telogen effluvium, a...

Anagen Effluvium
https://emedicine.medscape.com/article/1073488-overview

Apr 6th, 2021 - Background Normal human hairs can be classified according to the three phases of their growth cycle: anagen, catagen, and telogen. Anagen hairs are in a growing phase, during which the matrix cells of the hair follicle undergo vigorous mitotic act...

Anagen Effluvium
https://emedicine.medscape.com/article/1073488-print

Apr 6th, 2021 - Background Normal human hairs can be classified according to the three phases of their growth cycle: anagen, catagen, and telogen. Anagen hairs are in a growing phase, during which the matrix cells of the hair follicle undergo vigorous mitotic act...

Anagen Effluvium
http://emedicine.medscape.com/article/1073488-overview

Apr 6th, 2021 - Background Normal human hairs can be classified according to the three phases of their growth cycle: anagen, catagen, and telogen. Anagen hairs are in a growing phase, during which the matrix cells of the hair follicle undergo vigorous mitotic act...

see more →

News  3 results

Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies
https://www.mdedge.com/dermatology/article/237621/hair-nails
Christa Slaught, MD, Michael Roman, MD et. al.

Mar 24th, 2021 - Anagen effluvium during chemotherapy is common, typically beginning within 1 month of treatment onset and resolving by 6 months after the final course. 1 Permanent chemotherapy-induced alopecia (PCIA), in which hair loss persists beyond 6 months af.

Acute-Onset Alopecia
https://www.mdedge.com/dermatology/article/199906/hair-nails/acute-onset-alopecia?channel=113
Justin P. Bandino, MD, Dirk M. Elston, MD

Apr 30th, 2019 - The Diagnosis: Thallium-Induced Alopecia At the time of presentation, a punch biopsy specimen of the scalp revealed nonscarring alopecia with increased catagen hairs; follicular miniaturization; peribulbar lymphoid infiltrates; and fibrous tract r.

Acute-Onset Alopecia
https://www.mdedge.com/dermatology/article/199906/hair-nails/acute-onset-alopecia
Justin P. Bandino, MD, Dirk M. Elston, MD

Apr 30th, 2019 - The Diagnosis: Thallium-Induced Alopecia At the time of presentation, a punch biopsy specimen of the scalp revealed nonscarring alopecia with increased catagen hairs; follicular miniaturization; peribulbar lymphoid infiltrates; and fibrous tract r.

see more →

Patient Education  1 results

Hair Loss in Women: Causes, Trea
https://my.clevelandclinic.org/health/diseases/16921-hair-loss-in-women

Feb 10th, 2021 - Overview What’s hair loss in women? Hair loss in women is just that — when a woman experiences unexpected, heavy loss of hair. Generally, humans shed between 50 and 100 single hairs per day. Hair shedding is part of a natural balance — some hairs ...

see more →